A daily pill developed by the US pharmaceutical company Lilly may become a convenient alternative to injectable drugs like ...

If you're starting a semaglutide GLP-1 RA medication like Wegovy or Ozempic for weight loss, you may be wondering how soon ...

A spokesperson confirmed the Danish drugmaker has asked U.S. regulators to clear an oral version of its weight loss drug ...

Doctors and patients have been hoping for a pill version that would be easier to take, in contrast to an injectable.

Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...

A new oral weight-loss ... injections. The company plans to seek regulatory approval for the pill as an obesity treatment by the end of 2025, followed by a diabetes indication in 2026. Injectable ...

You’ve likely heard of well-known GLP-1 medications like Ozempic or Wegovy but some individuals are opting for specially made, compounded alternatives.

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, ...

Injectable medications originally developed for the treatment of diabetes are also effective for weight loss and have surged ...

This star posed a very shocking image to Instagram on Sunday. The mother of one - who got her start in stand-up comedy - has ...

In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body ...